Topic - Gary Lyman

Subscribe to this topic via RSS or ATOM
Related Stories

    No Stories Found

More Stories →

  • If even one of these studies shows a survival advantage for Avastin "that would be a game changer" although side effects remain a concern, said Dr. Gary Lyman.

    Studies: Avastin may fight early breast cancers →

  • Dr. Gary Lyman, a Duke University researcher who was on the FDA advisory panel that recommended revoking Avastin's approval for breast cancer, wrote in an email that he agreed with the company's decision not to seek approval for ovarian cancer.

    Avastin disappoints against ovarian cancer →

Happening Now